AMY KINTER: Open Payments
NPI 1649717398 · MIDDLETOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,403 in 59 payments from 33 companies in 2025. Trend: 2023 $244 · 2024 $857 · 2025 $1,403
Food & beverage: $1,311Education: $92
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $150 |
| Janssen Biotech, Inc. | 3 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $97 |
| Merck Sharp & Dohme LLC | 4 | $97 |
| Lilly USA, LLC | 4 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $79 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| PFIZER INC. | 2 | $47 |
| Madrigal Pharmaceuticals | 2 | $41 |
Products named: ERLEADA, XIFAXAN, KEYTRUDA QLEX, RINVOQ, DUPIXENT, ENTYVIO, TREMFYA, REBLOZYL.
Industry payments across OH — which companies pay providers there.
